Australia markets close in 5 hours 39 minutes

TherapeuticsMD, Inc. (29TA.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.71000.0000 (0.00%)
At close: 09:54PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 20.66M
Enterprise value 24.10M
Trailing P/E 0.46
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)14.69
Price/book (mrq)0.72
Enterprise value/revenue 18.51
Enterprise value/EBITDA -3.17

Trading information

Stock price history

Beta (5Y monthly) 1.04
52-week change 3-47.55%
S&P500 52-week change 323.10%
52-week high 34.0800
52-week low 31.6700
50-day moving average 31.9970
200-day moving average 32.4050

Share statistics

Avg vol (3-month) 31
Avg vol (10-day) 310
Shares outstanding 511.53M
Implied shares outstanding 612.08M
Float 89.91M
% held by insiders 11.90%
% held by institutions 143.42%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 309 May 2022

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-320.92%

Management effectiveness

Return on assets (ttm)-7.96%
Return on equity (ttm)-23.90%

Income statement

Revenue (ttm)1.3M
Revenue per share (ttm)0.12
Quarterly revenue growth (yoy)-99.30%
Gross profit (ttm)N/A
EBITDA -8.4M
Net income avi to common (ttm)-7.7M
Diluted EPS (ttm)-0.6900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.33M
Total cash per share (mrq)0.38
Total debt (mrq)8.01M
Total debt/equity (mrq)27.33%
Current ratio (mrq)1.72
Book value per share (mrq)2.54

Cash flow statement

Operating cash flow (ttm)-48.14M
Levered free cash flow (ttm)-34.19M